Jeffrey D. Marrazzo
Executive ChairMr. Jeffrey D. Marrazzo, also known as Jeff, is Chairman of nChroma Bio, Mr. Marrazzo founded and built Spark Therapeutics into the world’s first fully integrated, commercial gene therapy company, serving as co-founder and CEO from 2013 to 2022. He was Chief Business Officer of the U.S. division of Molecular Health, Inc. from 2011 until 2013. He was part of the Founding Management of Generation Health from 2009 until 2011. He serves on the Board of Director since May 2023 and as Executive Chair of our Board of Director since May 2025. Under Jeff’s leadership, Spark developed and launched LUXTURNA® for a rare blinding disorder, the first FDA-approved gene therapy for a genetic disease in the United States, spearheading the creation of novel reimbursement models to ensure patient access to genetic medicines. As CEO, Mr. Marrazzo shepherded multiple gene therapies into the clinic for patients with conditions ranging from inherited retinal diseases to rare bleeding and neuromuscular disorders. While at Spark, Mr. Marrazzo raised over 1 billion and established major partnerships with Pfizer and Novartis. Mr. Marrazzo's successful orchestration of Spark’s 4.8 billion sale to Roche in 2019 marked a 100-fold increase in the company’s market value over six years and delivered financial returns of 750 million to Spark’s non-traditional founding investor, Children’s Hospital of Philadelphia (CHOP). At the time of his departure, Spark had grown to 850 employees and was named #5 in Science magazine’s rankings of top employers across the biopharmaceutical industry. Mr. Marrazzo currently serves as a board member and strategic advisor to several biotechnology companies including Prime Medicine and Dispatch Bio, as well as on the boards of multiple non-profit organizations, including CHOP. In 2022, Mr. Marrazzo and his wife founded The Marrazzo Family Foundation with the goal of fostering creativity in Philadelphia youth. From 2008 until 2009 He served as an employee & Independent Consultant to the Business Development & Finance teams at Tengion Inc. Mr. Marrazzo has M.B.A. from University of Pennsylvania - The Wharton School. Mr. Marrazzo has B.A. in Economics, Systems Science, Engineering from University of Pennsylvania. Mr. Marrazzo has B.S.E. in Systems Science, Engineering from University of Pennsylvania. Mr. Marrazzo has M.P.A. in Public Administration from Harvard University. Mr. Marrazzo has M.B.A. from Harvard University. Mr. Marrazzo has Master's in Public Administration from University of Pennsylvania - The Wharton School.
Positions
- Company NamePrime Medicine, Inc.Stock CodePRMEPositionExecutive Chair
